EIC ePitching on MedTech: Call for EIC Fund‑selected MedTech companies to pitch to top European VCs
- ›The European Innovation Council is running an online MedTech ePitching session on 18 June 2024 for EIC Fund‑selected companies.
- ›Application deadline is 24 April 2024 and is open to EIC Accelerator beneficiaries that have an investment component or have been selected for investment.
- ›Selected companies will pitch to a panel of leading European venture capital firms and receive coaching and possible one‑to‑one follow ups.
- ›Applicant profiles and presenter details will be shared with jury members and may appear in an event brochure and future investor outreach.
- ›The initiative is part of the EIC Ecosystem Partnerships and Co‑Investment Support programme which aims to expand Business Acceleration Services and promote co‑investment.
EIC ePitching on MedTech: what the call offers and who should apply
The European Innovation Council is inviting EIC Fund‑selected MedTech companies to apply for an online ePitching session on 18 June 2024. The event will give a limited number of EIC Accelerator beneficiaries the chance to present their medical technology solutions to a panel of European venture capital investors. Organisers promise preparatory coaching, the opportunity to receive one‑to‑one meeting requests from investors and exposure through an event brochure and investor outreach. Applications must be submitted by 24 April 2024.
Logistics and participation requirements
When and where. The session is scheduled for 18 June 2024, running in the afternoon for about four hours. It will be held online. Selected beneficiaries will receive a Zoom link with joining instructions.
Who can apply. Eligibility is limited to EIC Accelerator companies that have been selected for or received the EIC investment component. This includes H2020 EIC Accelerator Pilot beneficiaries with blended finance packages and Horizon Europe EIC Accelerator companies that were selected under grant first, blended finance, or investment only tracks.
What selected companies receive and realistic expectations
The stated benefits are direct exposure to a panel of European investors, targeted coaching ahead of the event and potential follow up meetings. These are genuine advantages for early scale ups. At the same time it is important to be realistic. Pitching events increase visibility and can open doors but they do not guarantee investment. Selection by investors will reflect their current investment theses and portfolio needs, not only the quality of the technology.
The investors expected at the session
The organisers listed a group of established European investment firms that will be represented on the panel or may receive applicant profiles. That list includes Eleven Ventures, Hadean Ventures, High Tech Gruenderfonds, Inveready, Panakès Partners, Pathena Investments, Peppermint Venture Partners, Redalpine, MIG Capital AG, Sofinnova Partners, Turenne Capital and Zubi Capital. These firms cover a range of stages and sector specialisations from early stage deep tech and medtech specialists to growth oriented generalist funds.
| Investor | Approximate focus or role |
| Sofinnova Partners | Long established life sciences and medtech investor with pan‑European presence |
| High Tech Gründerfonds (HTGF) | Early stage German tech and life sciences investor, often active at pre‑seed and seed |
| Hadean Ventures | Life sciences and healthcare focused venture fund |
| Redalpine | Pan‑European VC investing at the intersection of software and science |
| Panakès Partners | Investor known for a healthcare and medtech focus |
| Inveready | Spanish VC active across technology and growth stages |
| Eleven Ventures | Early stage investor from the CEE region and pan‑European deals |
| MIG Capital | European life science and deep tech investor |
| Peppermint Venture Partners | Early stage investor, regional focus |
| Pathena Investments | Venture firm with activity in digital health and IT |
| Turenne Capital | Private equity and growth investor involved in European deals |
| Zubi Capital | Impact orientated investor with European co‑investment activity |
Note on accuracy. The table gives an approximate snapshot of typical fund orientations. Individual partner teams and their current investment priorities vary. Do not assume presence of any single investor at the event will lead to an investment offer. Use the session to gather investor feedback and to open targeted follow ups.
Context: how this fits into EIC support and co‑investment ambitions
Practical application checklist and pitch tips
Before you apply make sure you have the following in order and clearly presented in the application form and in any pitch materials.
Risks, limitations and recommendations
Pitch events are valuable but imperfect instruments for raising capital. They can surface investor interest quickly but selection often reflects narrow fund mandates and appetite at that time. Public sharing of applicant profiles increases exposure but can raise confidentiality concerns for companies with sensitive IP or competitive risks. Finally, the EIC reports that health is a dominant area in its portfolio and cites around €250 million in funding to date according to the EIC Impact Report. That funding number indicates EIC activity in the sector but it should not be read as a direct guarantee that participants will receive proportional follow on financing from event attendees.
Recommendation. Apply if you are eligible, prepared to present clear clinical and commercial evidence, and willing to engage in post‑event follow up. Use the coaching to sharpen your investor narrative and treat any one to one meetings as the start of a longer diligence process.
Contacts and further information
Application deadline: 24 April 2024. Event date: 18 June 2024. For questions about use of submitted information or objections to data sharing contact investments@eicfund.eu. For broader information about EIC Business Acceleration Services, the EIC Ecosystem Partnership Programme and co‑investment activities consult the EIC Community Platform and the EIC ACCESS+ materials on the EIC website.